ENDRA Life Sciences Inc.
NDRA
$4.87
$0.020.41%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.03M | -8.01M | -8.77M | -9.77M | -11.51M |
| Total Depreciation and Amortization | 157.30K | 164.20K | 178.80K | 196.10K | 206.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.67M | 2.49M | 2.95M | 2.97M | 3.77M |
| Change in Net Operating Assets | 22.70K | 267.60K | 56.10K | 50.50K | 134.10K |
| Cash from Operations | -5.18M | -5.09M | -5.58M | -6.55M | -7.40M |
| Capital Expenditure | -17.30K | -17.30K | -17.30K | -6.30K | -16.00K |
| Sale of Property, Plant, and Equipment | -- | 0.00 | 0.00 | 0.00 | 3.20K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.00M | -- | -- | -- | -- |
| Cash from Investing | -3.02M | -17.30K | -17.30K | -6.30K | -12.80K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 0.00 | 0.00 | 0.00 | -28.50K |
| Issuance of Common Stock | 5.73M | 2.47M | 2.32M | 8.80M | 9.16M |
| Repurchase of Common Stock | -- | -- | -1.32M | -1.32M | -1.32M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -1.32M | 0.00 | 0.00 | 0.00 |
| Cash from Financing | 5.73M | 1.15M | 1.00M | 7.49M | 7.81M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash | -2.47M | -3.95M | -4.59M | 930.20K | 395.60K |